Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl.oz. (10 mL) bottle, Distributed By Superchill Products, 827 6th Avenue, New York, New York 10001.
Published March 27, 2024 · Recall initiated: February 5, 2024
Summary
FDA records drug Class I recall D-0393-2024, published March 27, 2024 and initiated February 5, 2024. Recalling firm: Super Chill Products; Status: Terminated; Reported quantity: 3,573 bottles; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Super Chill Products
- Distributor
- Nationwide in the U.S.
- Lot
- All lots within expiry
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by HikmaMarch 27, 2024
- FDADole Chopped Kit Avocado Ranch UPC 71430000915March 27, 2024
- FDANicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics PharmaMarch 27, 2024
- FDADole Premium Kit Southwest Salad UPC 71430017012March 27, 2024
- FDANicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by:March 27, 2024
- FDADole Cajun Ranch Chopped Kit UPC 71430002063March 27, 2024
Questions about this recall
Was Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl.oz. (10 mL) bottle, Distributed By Superchill Products, 827 6th Avenue, New York, New York 10001. recalled?
Yes. FDA published recall D-0393-2024 on March 27, 2024. Reported hazard: Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
What should I do if I have this product?
Voluntary: Firm initiated · Letter